Screener
Rigel Pharmaceuticals RIGL Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $499.51M.
The source filing: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:05 PM EDT
- Fiscal quarter
- Q4 FY2026
- Calendar quarter
- Q4 2026
- Accession
- 0001034842-26-000032
FAQ
- What is Rigel Pharmaceuticals's market capitalization?
- Rigel Pharmaceuticals (RIGL) reported market capitalization of $499.51M in Q1 2026.
- How has Rigel Pharmaceuticals's market capitalization changed year-over-year?
- Rigel Pharmaceuticals's market capitalization increased by 55.4% year-over-year, from $321.35M to $499.51M.
- What is the long-term trend for Rigel Pharmaceuticals's market capitalization?
- Over 5 years (2020 to 2025), Rigel Pharmaceuticals's market capitalization has grown at a 5.4% compound annual growth rate (CAGR), from $598.52M to $777.42M.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Rigel Pharmaceuticals's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude